13D Filing: Wincrest Capital Ltd. and Tecogen Inc. (TGEN)

CUSIP No. 87876P201 13D

persons, for a common purpose should it determine to do
so, and/or to recommend courses of action to the Issuer’s
management, the Issuer’s Board of Directors, the Issuer’s
shareholders, and others.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

(a-e) Subsequent to having transferred its controlling interest
in the Issuer to a private investor, neither Wincrest,
Wincrest Contraria, nor Bernard have the sole power, nor
the shared power to dispose of, direct the disposition of,
vote, or direct the vote of Shares of the Issuer.

The Reporting Persons shall be deemed to have transferred in
total, all of their beneficial and controlling interests in
1,247,165 Shares of the Issuer through an in-kind
distribution to a private investor and beneficial owner of
Wincrest Contraria as of September 5, 2017.

As of the date hereof, the Reporting Persons no longer own
more than 5% of the total outstanding Common Shares of the
Issuer.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS, OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER.

The Reporting Persons do not have a contract, arrangement,
understanding, or relationship with any person with respect
to the Shares.

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.

Exhibit A: Joint Filing Statement